-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WFLSjcuDbO0m3+faANGqzzqNjLFbbHMOhAUFBbNx1NDzV9RfOvBaydAGJD6uXfSn WgT0nmZwZYaiA6+tvQOrUA== 0000875320-09-000086.txt : 20091015 0000875320-09-000086.hdr.sgml : 20091015 20091015154454 ACCESSION NUMBER: 0000875320-09-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091014 FILED AS OF DATE: 20091015 DATE AS OF CHANGE: 20091015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 091121443 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-10-14 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2009-10-14 4 M 0 6400 13.11 A 1072795 D Common Stock 2009-10-14 4 S 0 6400 34.20 D 1066395 D Common Stock 13286 I 401(k) Common Stock 207500 I Shares in trust Stock Options 13.11 2009-10-14 4 M 0 6400 0 D 2009-12-01 Common Stock 6400 38374 D Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $34.20 (range $33.90 to $34.54). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Shares held in trust for Dr. Boger's children. Dr. Boger disclaims beneficial ownership of such shares. Fully vested. Valerie L. Andrews, Attorney-In-Fact 2009-10-15 -----END PRIVACY-ENHANCED MESSAGE-----